In the present study, we found that IFNα treatment alone promoted the generation of erythroid cells in both RPS19-reduced primary erythroid cells and BM cells collected from DBA patients, whose erythroid cells were differentiated ex vivo. This evidence concerns the gene IFNA1 and Diamond-Blackfan anemia.